Cite
MLA Citation
M Chiorean et al.. “DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but not remission, after 52 weeks of maintenance therapy: data from the OCTAVE studies.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S049–S050. http://access.bl.uk/ark:/81055/vdc_100091276596.0x000010